Quotes 5-day view End-of-day quote Shenzhen Stock Exchange
Estimated financial data (e) CNY USD
5 834 M
Net income 2022
1 035 M
Net Debt 2022
P/E ratio 2022
5 782 M
Net income 2023
1 099 M
Net Debt 2023
P/E ratio 2023
29 067 M
4 338 M
4 338 M
Capi. / Sales 2022
Capi. / Sales 2023
Nbr of Employees
BGI Genomics Co. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology...
Ratings of BGI Genomics Co., Ltd.
All news about BGI GENOMICS CO., LTD.
06/28 BGI Genomics Announces Final Profit Distribution for 2021 payable on 06 July 2022
05/19 BGI Genomics Co., Ltd. Approves Cash Dividend for the Year 2021
05/12 Exclusive-Biden eyes new ways to bar China from scooping up U.S. data
05/09 BGI Genomics Develops Hepatitis Test Kits For Children
05/06 Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case
04/25 BGI Genomics Co., Ltd. Announces Final Cash Dividend Proposal for 2021
04/22 BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2..
03/25 New World Development Company Limited - Share for Good Receives Support from All Corner..
03/12 China approves five COVID-19 antigen kits for self-testing - CCTV
02/25 BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 20..
01/25 BGI Genomics Co., Ltd. announces an Increase in Equity Buyback.
01/09 BGI Genomics Wins Nod to Sell Cancer Tests Kits in Saudi Arabia; Shares Jump 3%
01/05 Tranche Update on BGI Genomics Co., Ltd.'s Equity Buyback Plan announced on October 29,..
2021 BGI Genomics Co., Ltd. agreed to acquire 11% stake in Shenzhen Zaozhidao Technology CO...
2021 Monkey-brain study with link to China's military roils top European university
News in other languages on BGI GENOMICS CO., LTD.
Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case
Chart BGI GENOMICS CO., LTD.
Technical analysis trends BGI GENOMICS CO., LTD.
Short Term Mid-Term Long Term Trends Bullish Bearish Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target